Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07513519 · ClinicalTrials.gov registry record · NA

Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial

A NA study, sponsored by BioMérieux.

Recruiting
Registry status
NA
Development phase
800
Enrollment target

NCT07513519 is a NA study that is actively recruiting participants, run by BioMérieux. The registered enrollment target is 800 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07513519, a NA study, is actively recruiting participants, sponsored by BioMérieux.

RECRUITING
Registry status
NA
Development phase
800 participants
Enrollment target

Study Summary

This research study will use a hybrid effectiveness-implementation type 1 design to assess effectiveness of the Spotfire R/ST assay in the urgent care setting. A hybrid effectiveness-implementation type 1 study primarily focuses on the effectiveness of an intervention (e.g., use of Spotfire R/ST) but also simultaneously allows for the collection of data on the barriers and facilitators of implementing the Spotfire R/ST test in the real-world urgent care setting.

Interventions

  • DEVICE SPOTFIRE R/ST Diagnostic Test

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2025-12-22
Est. Completion 2026-04
Phase NA

Sponsor

BioMérieux

8 total trials

What the Registry Record Tells You About NCT07513519

The ClinicalTrials.gov registry entry for NCT07513519 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioMérieux, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which SPOTFIRE R/ST Diagnostic Test is the first listed.

NCT07513519 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07513519 about?

NCT07513519 is a clinical study titled "Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial". This research study will use a hybrid effectiveness-implementation type 1 design to assess effectiveness of the Spotfire R/ST assay in the urgent care setting. A hybrid effectiveness-implementation type 1 study primarily focuses on the effectiveness of an intervention (e.g., use of Spotfire R/ST) bu...

What is the current status of trial NCT07513519?

This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2025-12-22. Estimated completion is 2026-04.

What interventions are being tested in trial NCT07513519?

The interventions under investigation include: SPOTFIRE R/ST Diagnostic Test (DEVICE).

Who is sponsoring clinical trial NCT07513519?

This trial is sponsored by BioMérieux, which has 8 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.